AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842 | +24.6% | 739 | 0.0% | 0.00% | – |
| Q2 2023 | $676 | +63.3% | 739 | 0.0% | 0.00% | – |
| Q1 2023 | $414 | – | 739 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 739 | -23.3% | 0.00% | – |
| Q3 2022 | $0 | – | 963 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 963 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 963 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 963 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -93.9% | 963 | -92.6% | 0.00% | – |
| Q2 2021 | $49,000 | +8.9% | 13,056 | 0.0% | 0.00% | – |
| Q1 2021 | $45,000 | +25.0% | 13,056 | +0.8% | 0.00% | – |
| Q4 2020 | $36,000 | +800.0% | 12,956 | +679.5% | 0.00% | – |
| Q3 2020 | $4,000 | -92.5% | 1,662 | -57.5% | 0.00% | – |
| Q2 2020 | $53,000 | -41.1% | 3,909 | -67.1% | 0.00% | – |
| Q1 2020 | $90,000 | – | 11,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |